Agilent Technologies (A) Stock Price, News & Analysis

Company Overview

Agilent Technologies, Inc. is a global leader in life sciences, diagnostics and applied chemical markets. Headquartered in Santa Clara, California, the company designs and manufactures analytical instruments, software, services and consumables for laboratories engaged in pharmaceutical R&D, clinical diagnostics, food safety, environmental testing and chemical analysis. Agilent’s core offerings include chromatography systems, mass spectrometers, spectroscopic analyzers, microarrays, reagents and laboratory automation solutions.

Formed in 1999 as a spin-off from Hewlett-Packard’s scientific instruments business, Agilent has expanded its portfolio through targeted acquisitions and organic innovation. In 2014 the company completed the separation of its electronic measurement segment to create Keysight Technologies, allowing Agilent to focus exclusively on the life sciences and diagnostics markets. Subsequent acquisitions and internal R&D have bolstered capabilities in genomics, cell analysis and lab informatics.

Agilent serves a broad array of customers across more than 100 countries, operating in the Americas, Europe, Middle East and Africa, and the Asia-Pacific region. Its products support applications ranging from drug discovery and biopharmaceutical production to environmental monitoring, food safety testing and semiconductor materials analysis. The company maintains regional application laboratories, customer support centers and distribution networks to ensure technical service and rapid deployment of solutions worldwide.

Under the leadership of President and Chief Executive Officer Michael R. McMullen, Agilent continues to pursue growth in high-value markets by advancing measurement science and enabling laboratories to improve productivity and data quality. The company’s commitment to innovation and customer collaboration positions it as a key partner for organizations seeking to address complex challenges in healthcare, sustainability and technology development.

Key Stats

• Today's Range: $113.53 to $117.20
• 50-Day Range: $108.61 to $124.18
• 52-Week Range: $96.43 to $153.84
• Volume: 1.52 million shs
• Average Volume: 1.86 million shs
• Market Capitalization: $32.38 billion
• P/E Ratio: 28.14
• Dividend Yield: 0.87%
• Price Target: $139.77
• Consensus Rating: Moderate Buy

Agilent Technologies Stock Analysis - MarketRank™

Agilent Technologies scored higher than 95% of companies evaluated by MarketBeat, and ranked 67th out of 933 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Agilent Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.54, and is based on 7 buy ratings, 6 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Agilent Technologies has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 8.96%

Earnings Growth

Earnings for Agilent Technologies are expected to grow by 8.96% in the coming year, from $5.58 to $6.08 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Agilent Technologies is 28.14, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.49.

Price to Earnings Ratio vs. Sector

The P/E ratio of Agilent Technologies is 28.14, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.01.

Price to Earnings Growth Ratio

Agilent Technologies has a PEG Ratio of 3.53. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Agilent Technologies has a P/B Ratio of 5.55. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.18% of the float of Agilent Technologies has been sold short.

Short Interest Ratio / Days to Cover

Agilent Technologies has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Agilent Technologies has recently decreased by 18.49%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Agilent Technologies has a dividend yield of 0.85%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Agilent Technologies has been increasing its dividend for 9 years.

Dividend Coverage

The dividend payout ratio of Agilent Technologies is 24.44%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Agilent Technologies will have a dividend payout ratio of 16.28% next year. This indicates that Agilent Technologies will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.6 / 5
• Environmental Score: -1.83

Percentage of Shares Shorted

1.18% of the float of Agilent Technologies has been sold short.

Short Interest Ratio / Days to Cover

Agilent Technologies has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Agilent Technologies has recently decreased by 18.49%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 1.10

News Sentiment

Agilent Technologies has a news sentiment score of 1.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 24 news articles for Agilent Technologies this week, compared to 18 articles on an average week.

Search Interest

38 people have searched for A on MarketBeat in the last 30 days. This is an increase of 73% compared to the previous 30 days.

MarketBeat Follows

Only 2 people have added Agilent Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Agilent Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $178,032.00 in company stock.

A Stock Analysis - Frequently Asked Questions

How have A shares performed this year?

Agilent Technologies' stock was trading at $134.34 at the start of the year. Since then, A shares have decreased by 15.2% and is now trading at $113.97.

How were Agilent Technologies' earnings last quarter?

Agilent Technologies, Inc. (NYSE:A) announced its earnings results on Wednesday, May, 28th. The medical research company reported $1.31 EPS for the quarter, beating analysts' consensus estimates of $1.26 by $0.05. Agilent Technologies's quarterly revenue was up 6.0% on a year-over-year basis.
Read the conference call transcript.

Does Agilent Technologies have any subsidiaries?

The following companies are subsidiaries of Agilent Technologies: Resolution Bioscience, BioTek Instruments, ACEA BIO, Young In Scientific Co. Ltd, ProZyme Inc, ULTRA Scientific, Genohm, and others.

Who are Agilent Technologies' major shareholders?

Top institutional investors of Agilent Technologies include Gateway Investment Advisers LLC (0.06%), Swedbank AB (0.06%), Quintet Private Bank Europe S.A. (0.04%) and Janney Montgomery Scott LLC (0.04%). Insiders that own company stock include Michael R Mcmullen, Jacob Thaysen, Henrik Ancher-Jensen, Boon Hwee Koh, Heidi Fields, Michael Tang, Dominique Grau, Padraig Mcdonnell, Daniel K Podolsky, Rodney Gonsalves, Philip Binns and Judy L Brown.
View institutional ownership trends.

How do I buy shares of Agilent Technologies?

Shares of A stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Agilent Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Agilent Technologies investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), Voyager Therapeutics (VYGR) and iShares Micro-Cap ETF (IWC).

Company Calendar

• Record date for 4/23 Dividend: 4/01/2025
• Ex-Dividend for 4/23 Dividend: 4/01/2025
• Dividend Payable: 4/23/2025
• Last Earnings: 5/28/2025
• Record date for 7/23 Dividend: 7/01/2025
• Ex-Dividend for 7/23 Dividend: 7/01/2025
• Today: 7/18/2025
• Dividend Payable: 7/23/2025
• Next Earnings (Confirmed): 8/27/2025
• Fiscal Year End: 10/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NYSE:A
• CIK: 1090872
• Web: www.agilent.com
• Phone: (800) 227-9770
• Fax: 408-345-8474
• Employees: 17,900
• Year Founded: 1999

Price Target and Rating

• Average Price Target for Agilent Technologies: $139.77
• High Price Target: $165.00
• Low Price Target: $116.00
• Potential Upside/Downside: +22.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.54
• Research Coverage: 13 Analysts

Profitability

• EPS (Trailing Twelve Months): $4.05
• Trailing P/E Ratio: 28.14
• Forward P/E Ratio: 20.42
• P/E Growth: 3.44
• Net Income: $1.29 billion
• Net Margins: 17.59%
• Pretax Margin: 20.68%
• Return on Equity: 25.92%
• Return on Assets: 13.24%

Debt

• Debt-to-Equity Ratio: 0.55
• Current Ratio: 2.09
• Quick Ratio: 1.60

Sales & Book Value

• Annual Sales: $6.51 billion
• Price / Sales: 4.97
• Cash Flow: $6.28 per share
• Price / Cash Flow: 18.15
• Book Value: $20.53 per share
• Price / Book: 5.55

Miscellaneous

• Outstanding Shares: 284,070,000
• Free Float: N/A
• Market Cap: $32.38 billion
• Optionable: Optionable
• Beta: 1.23